BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huber S, Braun NJ, Schmacke LC, Quek JP, Murra R, Bender D, Hildt E, Luo D, Heine A, Steinmetzer T. Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors. J Med Chem 2022. [PMID: 35475620 DOI: 10.1021/acs.jmedchem.1c01860] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 van den Elsen K, Chew BLA, Ho JS, Luo D. Flavivirus nonstructural proteins and replication complexes as antiviral drug targets. Curr Opin Virol 2023;59:101305. [PMID: 36870091 DOI: 10.1016/j.coviro.2023.101305] [Reference Citation Analysis]
2 Braun NJ, Huber S, Schmacke LC, Heine A, Steinmetzer T. Boroleucine-Derived Covalent Inhibitors of the ZIKV Protease. ChemMedChem 2023;18:e202200336. [PMID: 36325810 DOI: 10.1002/cmdc.202200336] [Reference Citation Analysis]
3 Zephyr J, Rao DN, Johnson C, Shaqra AM, Nalivaika EA, Jordan A, Kurt Yilmaz N, Ali A, Schiffer CA. Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease. Bioorg Chem 2023;131:106269. [PMID: 36446201 DOI: 10.1016/j.bioorg.2022.106269] [Reference Citation Analysis]
4 Hammerschmidt SJ, Huber S, Braun NJ, Lander M, Steinmetzer T, Kersten C. Thermodynamic characterization of a macrocyclic Zika virus NS2B/NS3 protease inhibitor and its acyclic analogs. Arch Pharm (Weinheim) 2022;:e2200518. [PMID: 36480352 DOI: 10.1002/ardp.202200518] [Reference Citation Analysis]
5 Dos Santos Nascimento IJ, da Silva Rodrigues ÉE, da Silva MF, de Araújo-Júnior JX, de Moura RO. Advances in Computational Methods to Discover New NS2B-NS3 Inhibitors Useful Against Dengue and Zika Viruses. Curr Top Med Chem 2022;22:2435-62. [PMID: 36415099 DOI: 10.2174/1568026623666221122121330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]